Nuvation Bio, Inc. (NUVB)
4.41
-0.10
(-2.22%)
USD |
NYSE |
Apr 02, 16:00
4.40
-0.01
(-0.23%)
After-Hours: 20:00
Nuvation Bio Profit Margin (Quarterly) : -87.40% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 11.83% |
| Aldeyra Therapeutics, Inc. | -- |
| Biohaven Ltd. | -- |
| Niagen Bioscience, Inc. | 12.21% |
| Ultragenyx Pharmaceutical, Inc. | -62.32% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.20% |
| Return on Assets | -35.57% |
| Return on Invested Capital | -40.40% |
| Gross Profit Margin (Quarterly) | 95.66% |
| Operating Margin (Quarterly) | -81.30% |
| Return on Net Operating Assets | -663.5% |